Inventor · disambiguated record
Soheil Meshinchi
Also filed as: MESHINCHI SOHEIL
1 granted patent·6 pending applications·0 citations·filing 2020–2023
10Inventor score
Files withFRED HUTCHINSON CANCER CENTER5SEATTLE CHILDRENS HOSPITAL DBA SEATTLE CHILDRENS RES INST1SUTRO BIOPHARMA INC1
Top patents by PatentIndex Score
7 records- 0157US11987640B2Anti-mesothelin antigen-binding molecules and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2021·Granted May 21, 2024·0 cites·12 claims
- 0254US2024148890A1Anti-folate receptor conjugate therapy for cancer treatmentSUTRO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 0348US2024165255A1Anti-folate receptor conjugate therapy for cancer treatmentFRED HUTCHINSON CANCER CENTER·Filed 2023·Application pending·0 cites
- 0447US2024091260A1Chimeric antigen receptors that bind preferentially expressed antigen in melanoma (prame)/hla-a2 to treat cancerFRED HUTCHINSON CANCER CENTER·Filed 2023·Application pending·0 cites
- 0547US2025025557A1Treatments for cancers utilizing cell-targeted therapies and associated research protocolsFRED HUTCHINSON CANCER CENTER·Filed 2022·Application pending·0 cites
- 0639US2022195441A1Combinatorial car t cell and hematopoeitic stem cell genetic engineering for specific immunotherapy of myeloid leukemiasSEATTLE CHILDRENS HOSPITAL DBA SEATTLE CHILDRENS RES INST·Filed 2020·Application pending·0 cites
- 0739US2024009239A1Therapeutic targeting of mesothelin in acute myeloid leukemia with chimeric antigen receptor t cell therapyFRED HUTCHINSON CANCER CENTER·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Soheil Meshinchi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →